Dedicated to the development of new generation of kinase inhibitors based drug candidates
OriBase Pharma is fully dedicated to the discovery & early development of novel & best-in-class targeted therapies (kinase inhibitors) from discovery to clinical validation for indications with high and unmet medical needs in oncology.
Our mission is to deliver safe, drug-like novel molecular entities (NCEs and NBEs) ready for clinical trials through the application of a unique technology platform & efficient discovery processes. Our commitment is to accomplish this with the highest quality & speed.
Scientific Advisory Board
OriBase Pharma is supported by a highly experienced Scientific Advisory Board that has followed the company since its creation in 2007 (formerly Nova Decision & Azasynth...
Read more ...
Kinase Inhibitor
Our expertise comes from the deep understanding of the various mechanisms of potential inhibitors and their interaction and binding kinases.
Read more ...
